Chemo drugs commonly used to treat cervical cancer Treatment choices are made based on each person's needs. Drugs that have been used include: Cisplatin Carboplatin Bevacizumab (Avastin) Paclitaxel ...

New technique preserves major nerves, blood vessels, and other critical structures in a hard-to-access area. In a ...

Finding cervical cancer often starts with an abnormal HPV (human papillomavirus) or Pap test result. This will lead to further tests which can diagnose cervical cancer or pre-cancer. The Pap test and ...

Women aged 25–49 years living in England considered at low risk of cervical cancer following testing will now be invited for screening every 5 years instead of every 3 years. The changes, announced by ...

In fact, several potential organic causes for globus pharyngeus were supposed, such as lingual tonsillar hypertrophy, cervical osteophytes, iron deficiency anemia, temporomandibular joint disorder ...

Each item explores a different symptom in the domain of globus pharyngeus. In its original form, the GETS showed a good reliability, with a Cronbach alpha value of 0.83.

Donald Trump and his FBI director have a new conspiracy theory about Trump's 2020 defeat. It's underwhelming, even by their standards.

An Oklahoma woman says she’s had two encounters with Oklahoma police officers in less than two weeks over her personalized plate that’s been flagged as stolen out of Texas.

Abstract The osteological variations present in the cervical vertebrae of pterosaurs represent changes in the soft tissues of the neck and reflect their function. Here, we infer the presence, volume, ...

Cervical screening, while not a diagnostic test, is for people without symptoms and aims to detect early changes which could go on to develop into cervical cancer if left untreated.

In honoring these two writers, the James Beard Foundation didn’t just award excellence in writing. It recognized memory as a form of resistance – and Palestine, not as a fading cause, but as a living ...

Globus Maritime (NASDAQ:GLBS) First Quarter 2025 Results Key Financial Results Revenue: US$8.62m (up 12% from 1Q 2024). Net loss: US$1.48m (loss widened by 396% from 1Q 2024).